COPE
Volume 6, Issue 2 (May 2018)                   Res Mol Med (RMM) 2018, 6(2): 12-20 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Gheitani L, Fazeli H. Prevalence of bla VIM, bla IMP, and bla KPC Genes among Carbapenem-Resistant Klebsiella pneumoniae (CRKP) Isolated from Kurdistan and Isfahan Hospitals, Iran. Res Mol Med (RMM). 2018; 6 (2) :12-20
URL: http://rmm.mazums.ac.ir/article-1-276-en.html
Abstract:   (837 Views)
Background: Carbapenem resistance among Klebsiella pneumoniae is an emerging problem worldwide. One of the main mechanisms of resistance to carbapenems is the potential of Klebsiella pneumoniae to produce carbapenemase enzyme.This study was conducted to determine the frequency of blaVIM, blaIMP, and blaKPC among carbapenem-resistant K. pneumoniae (CRKP) isolated from Kurdistan and Isfahan hospitals.
Materials and methods: This study was carried out in Iran using 183 samples from the Besat and Alzahra hospitals in 2017. Antibiotic susceptibility tests were performed by Kirby-Bauer disc diffusion. The modified Hodge test (MHT) was used to investigate the presence of carbapenemase. The β -lactamases genes were detected by PCR.
Results: The highest and lowest rates of resistance were observed against cefotaxime (98.2%) and gentamicin (43.6%), respectively. Among the 183 isolates, 134 (73.2 %) were positive by the MHT. The prevalence rates of blaVIM, blaIMP, and blaKPC were 4 (2.18%), 1 (0.5%), and 0%, respectively.
Conclusion: The prevalence of CRKP strains is a major concern and infection control processes are needed. These gene showed a low prevalence in our country, likely because other mechanisms of resistance to carbapenems are involved.
 
Full-Text [PDF 4991 kb]   (244 Downloads)    
Type of Study: Research | Subject: Medical bacteriology
Received: 2018/10/10

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2019 All Rights Reserved | Research in Molecular Medicine

Designed & Developed by : Yektaweb